The History of Terrorism
Preview
Open in TheBrain
Links
FDA's COVID-19 Fasttrack Trials
2020 GEN - Moderna's SARS-CoV-2 Vaccine's Fast Track to Clinical Trials
. . . . One of the reasons the SARS-CoV-2 vaccine development has been so fast (for details, see the timeline of events at the bottom of the story) is the work Moderna has done over the past two years in an existing...
...with the Vaccine Research Center (VRC) of NIAID to develop a vaccine against MERS-CoV. . . .
. . . . When the company received the SARS-CoV-2 genomic sequences from China on January 11, the stage was already set.
The mRNA vaccine against SARS-CoV-2 (mRNA-1273) was quickly designed, tested for sterility, and shipped to the NIAID for clinical study. ...
...The IND was filed on February 21 and, on March 2, FDA gave the green light to start clinical study. The first person was dosed last Monday and the company is currently filing an IND to start Phase II. . . .
. . . . The biggest reason for Moderna's progress on this vaccine is because a lot of the work had been done before-given the time and energy they invested into the MERS vaccine. ...
...He explained that, without that, they never would have been able to move as fast. . . .
Attachments
Working...
Parents
. . . . The biggest reason for Moderna's progress on this vaccine is because a lot of the work had been done before-given the time and energy they invested into the MERS vaccine. ...